Potentially Inappropriate Medications Criteria-Based Tools for The

Potentially Inappropriate Medications Criteria-Based Tools for The

Potentially inappropriate medications criteria-based tools for the elderly: a systematic scoping review Geovana Schiavo,1 Marcela Forgerini,1 Rosa Camila Lucchetta,1 Patricia de Carvalho Mastroianni.1 1 Department of Drugs and Medicines, Faculty of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil. Corresponding author: Professora Dr. Patricia de Carvalho Mastroianni E-mail: [email protected] (+55 16) 3301-6977 Adjunct Professor, Department of Drugs and Medicines, Faculty of Pharmaceutical Sciences, São Paulo State University (UNESP) Highway Jaú, Km 01 s / n 14800-901, Araraquara SP- Brazil. Summary Table 1. Search strategies in databases PubMed and Scopus. ................................................................................. 2 Figure 1. Selection process for review studies (adapted from PRISMA-ScR) - Potentially inappropriate medications tools in the elderly ............................................................................................................................... 3 Figure 2. Selection process for review studies (adapted from PRISMA-ScR) - Potentially inappropriate drug interactions for elderly with respiratory diseases ................................................................................................... 4 Figure 3. Selection process for review studies (adapted from PRISMA-ScR) - Potentially inappropriate drug interactions for elderly people with mental and behavioral disorders ..................................................................... 5 Table 2. Excluded records. ...................................................................................................................................... 6 Table 3. Commercialization and essentiality of potentially inappropriate medications for elderly. ...................... 14 Table 4. Ten potentially inappropriate medication with a higher number of citations by tools, in decreasing order of citations. ............................................................................................................................................................ 23 Table 5. Ten potentially inappropriate classes of medication with the highest number of citations by tools, in decreasing order. ................................................................................................................................................... 27 Table 6. Medication or pharmacological classes with the highest number of interactions. ................................... 28 Table 7. Potentially inappropriate interactions between potentially inappropriate drugs and morbidities/syndromes classified according to the International Statistical Classification of Diseases and Related Health Problems – 10th revision. ................................................................................................................................................................. 34 Table 8. Potentially inappropriate interaction (drug/pharmacological class), according three respiratory diseases classified according to the International Statistical Classification of Diseases and Related Health Problems – 10th revision. ................................................................................................................................................................ 37 Table 9. Potentially inappropriate interaction (drug/pharmacological class), according six mental and behavioral disorders classified according to the International Statistical Classification of Diseases and Related Health Problems – 10th revision. ....................................................................................................................................... 38 Table 10. Reasons, therapeutic management for potentially inappropriate interaction (drug/pharmacological class), according six mental and behavioral disorders classified according to the International Statistical Classification of Diseases and Related Health Problems – 10th revision. ......................................................................................... 40 Table 11. Potentially inappropriate medications with adverse drug reactions in the mental and behavioral disorders. ............................................................................................................................................................................... 47 References ............................................................................................................................................................. 72 Table 1. Search strategies in databases PubMed and Scopus. PUBMED #1 Population elderly[TIAB] OR aged[MH] OR aged[TIAB] OR “older adult*”[TIAB] OR “older people”[TIAB] OR geriatric[TIAB] #2 Concept (((inappropriate[TIAB] OR appropriateness[TIAB]) AND (medication*[TIAB] OR prescri*[TIAB])) OR “inappropriate prescribing”[MH] OR “Potentially Inappropriate Medication List”[MH] OR Deprescriptions[MH] OR deprescription*[TIAB] OR “PIM”[TIAB]) #3 (tool[TIAB] OR criteria[TIAB] OR list[TIAB] OR consensus[TIAB] OR consensus[MH]) #4 Context (review[PT] OR meta-analysis[PT] OR news[PT] or letter[PT] OR editorial[PT] and types OR historical article[PT]) of studies #5 Final ((#1 AND #2 AND #3) NOT #4) search strategy SCOPUS #1 Population TITLE-ABS-KEY(elderly OR aged OR aged OR "older adult" OR "older adults" OR "older people" OR geriatric) #2 Concept TITLE-ABS-KEY(((inappropriate OR appropriateness) AND (medication* OR prescri*)) OR "inappropriate prescribing" OR "Potentially Inappropriate Medication List" OR deprescription* OR PIM) #3 TITLE-ABS-KEY(tool OR criteria OR list OR consensus) #4 Context and types DOCTYPE ( bk OR ch OR cr OR ed OR le) of studies #5 (INDEX(medline)) #6 Final search #1 AND #2 AND #3 AND NOT #4 AND NOT #5 strategy Figure 1. Selection process for review studies (adapted from PRISMA-ScR) - Potentially inappropriate medications tools in the elderly Database Manual search (n = 2,467) (n = 10) Identification Records after duplicates removed (n = 2,370) Screening Records screened (n = 2,380) Records excluded (n = 2,273) Eligibility Full-text articles assessed for eligibility (n = 107) Full-text articles excluded, with reasons (n = 53) Articles included in scoping review Included (n = 54) Figure 2. Selection process for review studies (adapted from PRISMA-ScR) - Potentially inappropriate drug interactions for elderly with respiratory diseases Manual search Database (n = 10) (n = 2,467) Identification Records after duplicates removed (n = 2,370) Screening Records screened (n = 2,380) Records excluded (n = 2,273) Eligibility Full-text articles assessed for eligibility (n = 107) Full-text articles excluded, with reasons (n = 53) Articles included in scoping review Included (n = 54) Full-text articles excluded because do not include PIM or PII of respiratory diseases (n = 35) Articles included in respiratory analysis (n = 19) PIM: potentially inappropriate medication; PII: potentially inappropriate interactions. Figure 3. Selection process for review studies (adapted from PRISMA-ScR) - Potentially inappropriate drug interactions for elderly people with mental and behavioral disorders Database Manual search 2,467 (n = 10) Identification Records after duplicates removed (n = 2,370) Screening Records screened (n = 2,379) Records excluded (n = 2,273) Eligibility Full-text articles assessed for eligibility (n = 107) Full-text articles excluded, with reasons (n = 53) Articles included in scoping review Included (n = 54) Full-text articles excluded because do not include PIM or PII of mental or behavior Articles included in mental disorders (n = 17) and behavior analysis (n = 37) PIM: potentially inappropriate medication; PII: potentially inappropriate interactions. Table 2. Excluded records. Population 1. Nery, Raiany Thaimeny ;Reis, Adriano Max Moreira Development of a Brazilian anticholinergic activity drug scale 2019 Einstein (Sao Paulo, Brazil) 17 2 eAO4435-eAO 10.31744/einstein_journal/2019AO4435 Concept 2. Vrijkorte, Elze ;de Vries, Jennifer ;Schaafsma, Ron ;Wymenga, Machteld ;Oude Munnink, Thijs Optimising pharmacotherapy in older cancer patients with polypharmacy 2020 European journal of cancer care 29 1 e13185-e 10.1111/ecc.13185 3. Rodríguez-Pérez, A. ;Alfaro-Lara, E. R. ;Sierra-Torres, M. I. ;Villalba-Moreno, Á ;Nieto-Martin, M. D. ;Galván-Banqueri, M. ;Santos-Ramos, B. Validation of the LESS-CHRON criteria: Reliability study of a tool for deprescribing in patients with multimorbidity 2019 European Journal of Hospital Pharmacy 26 6 334-8 10.1136/ejhpharm-2017-001476 4. Rabenberg, Andree ;Schulte, Timo ;Hildebrandt, Helmut ;Wehling, Martin The FORTA (Fit fOR The Aged)-EPI (Epidemiological) Algorithm: Application of an Information Technology Tool for the Epidemiological Assessment of Drug Treatment in Older People 2019 Drugs & aging 36 10 969-78 10.1007/s40266-019- 00703-7 5. Kympers, C. ;Tommelein, E. ;Van Leeuwen, Ellen ;Boussery, K. ;Petrovic, M. ;Somers, A. Detection of potentially inappropriate prescribing in older patients with the GheOP³S-tool: completeness and clinical relevance 2019 Acta clinica Belgica 74 2 126-36 10.1080/17843286.2019.1568353 6. Jun, Kwanghee ;Hwang, Sunghee ;Ah, Young-Mi ;Suh, Yewon ;Lee, Ju-Yeun Development of an Anticholinergic Burden Scale specific for Korean older adults 2019 Geriatrics & gerontology international 19 7 628-34 10.1111/ggi.13680 7. Ivanova, Ivana ;Elseviers, Monique ;Wettermark, Bjorn ;Schmidt Mende, Katharina ;Vander Stichele, Robert ;Christiaens, Thierry Electronic assessment

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    74 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us